23andMe | Investor Presentation Deck | 39 slides · page 6 of 39
The slide highlights the competitive advantage of scale and recontactability, supported by a callout on consent rates and a metric on drug success probability.
Pitch deck · unfair_advantage · show_traction · dense density
Slide locked Sign in to view
Slide schematic 7/7
callout 1/1 chart 1/1 image 1/1 list 1/1 metric 1/1 title 2/2
Components 7
primary bar-horizontal logo-grid bullet big-number action-title headline
Tools 2
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1